In conclusion, our study highlights potential blood-derived biomarkers, including IL-1β, IL-6, TNF-α, CRP, and CCL2, for the diagnosis, prognosis, and progression evaluation of MDD with suicide-related behaviors. The gene discussed is CCL2; the disease is major depressive disorder.